Fidaxomicin (trade names Dificid, Dificlir, and previously OPT-80 and PAR-101) is the first in a new class of narrow spectrum macrocyclic antibiotic drugs. It is a fermentation product obtained from the actinomycete Dactylosporangium aurantiacum subspecies hamdenesis. Fidaxomicin is non-systemic, meaning it is minimally absorbed into the bloodstream, it is bactericidal, and it has demonstrated selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that make up the normal, healthy intestinal flora. The maintenance of normal physiological conditions in the colon can reduce the probability of Clostridium difficile infection recurrence. ; It is marketed by Cubist Pharmaceuticals after ac of its originating company Optimer Pharmaceuticals. The target use is for treatment of Clostridium difficile infection.
10000+种丰富多样的化学试剂和原料可供选择,从通用有机试剂、无机试剂、高纯试剂、电子纯试剂、分析纯试剂、优级纯试剂、色谱纯试剂、基准试剂、环保试剂、指示剂、标准溶液、卡尔费休等化学试剂,涵盖各类别,满足不同需求。
广东大小化工有限公司 是集生产与销售于一体的行业翘楚,拥有强大的源头供应链,外贸进出口业务畅通无阻,凭借完善的产品供应体系,10000+种丰富多样的化学试剂和原料可供选择,从通用有机试剂、无机试剂、高纯试剂、电子纯试剂、分析纯试剂、优级纯试剂、色谱纯试剂、基准试剂、环保试剂、指示剂、标准溶液、卡尔费休等化学试剂,涵盖各类别,满足不同需求。公司资质齐全,可办理危包、商检、两用物项手续,持证合法经营各类化学品。我们坚持快速响应,以专业的团队...